Ivermectin: all 162 studies that test it

Page 2 of 2. Open to participants first (12), then studies with results posted, then the rest; newest registration first within each.

• Prophylaxis Covid-19 in Healthcare Agents by Intensive Treatment With Ivermectin and Iota-carrageenanCompletedNCT04701710Phase 1/2
• Efficacy and Safety of Ivermectin for Treatment and Prophylaxis of COVID-19 PandemicCompletedNCT04668469Not applicable
• Randomized Phase IIA Clinical Trial to Evaluate the Efficacy of Ivermectin to Obtain Negative PCR Results in Patients With Early Phase COVID-19CompletedNCT04635943Phase 2
• Ivermectin in Adults With Severe COVID-19.TerminatedNCT04602507Phase 2
• Ivermectin to Prevent Hospitalizations in COVID-19CompletedNCT04529525Phase 2/3
• Effectiveness and Safety of Ivermectin for the Prevention of Covid-19 Infection in Colombian Health PersonnelStatus unknownNCT04527211Phase 3
• Ivermectin Nasal Spray for COVID19 PatientsStatus unknownNCT04510233Phase 2
• Trial of Combination Therapy to Treat COVID-19 InfectionCompletedNCT04482686Phase 1
• Efficacy of Subcutaneous Ivermectin With or Without Zinc in COVID-19 PatientsStatus unknownNCT04472585Phase 1/2
• Early Treatment With Ivermectin and LosarTAN for Cancer Patients With COVID-19 InfectionTerminatedNCT04447235Phase 2
• A Preventive Treatment for Migrant Workers at High-risk of COVID-19CompletedNCT04446104Phase 3
• Ivermectin in Treatment of COVID-19Status unknownNCT04445311Phase 2/3
• COVidIVERmectin: Ivermectin for Treatment of Covid-19TerminatedNCT04438850Phase 2
• A Study to Compare the Efficacy and Safety of Different Doses of Ivermectin for COVID-19TerminatedNCT04431466Phase 2
• Ivermectin vs. Placebo for the Treatment of Patients With Mild to Moderate COVID-19Status unknownNCT04429711Not applicable
• Ivermectin In Treatment of COVID 19 PatientsStatus unknownNCT04425707Not applicable
• Efficacy of Ivermectin in Adult Patients With Early Stages of COVID-19 (EPIC Trial)CompletedNCT04405843Phase 2/3
• Ivermectin as a Novel Therapy in COVID-19 TreatmentCompletedNCT04403555Phase 2/3
• Ivermectin-Azithromycin-Cholecalciferol (IvAzCol) Combination Therapy for COVID-19CompletedNCT04399746Not applicable
• Efficacy of Ivermectin in COVID-19Status unknownNCT04392713Not applicable
• Comparative Study of Hydroxychloroquine and Ivermectin in COVID-19 ProphylaxisStatus unknownNCT04384458Not applicable
• Max Ivermectin- COVID 19 Study Versus Standard of Care Treatment for COVID 19 Cases. A Pilot StudyStatus unknownNCT04373824Not applicable
• Ivermectin and Nitazoxanide Combination Therapy for COVID-19Status unknownNCT04360356Phase 2/3
• Ivermectin Safety in Small ChildrenCompletedNCT04332068Phase 2
• Bioequivalence Study of Ivermectin Cream 1% in Treatment of Moderate to Severe Facial RosaceaCompletedNCT04106726Phase 3
• Safety and Efficacy of Annual or Biannual Doses of Moxidectin or Ivermectin for OnchocerciasisActive, not recruitingNCT03876262Phase 3
• Ivermectin Treatment of Persons With Onchocerciasis-associated EpilepsyCompletedNCT03852303Phase 4
• Effect of Ivermectin Metabolites on Mosquito SurvivalCompletedNCT03690453Phase 4
• PK PD Study of IDA and Azithromycin for NTDs ( ComboNTDs )CompletedNCT03664063Phase 2
• Treatment of Pediculosis (Head Lice) in SenegalCompletedNCT03578679Not applicable
• Mass Drug Administration of Ivermectin and Dihydroartemisinin-piperaquine as an Additional Intervention for Malaria EliminationCompletedNCT03576313Phase 3
• Open-label Pilot Clinical Trial of Oral Ivermectin to Treat Atopic DermatitisWithdrawnNCT03553615Phase 2
• Ocular Changes After Ivermectin - (DOLF IVM/Oncho)CompletedNCT03517462Not applicable
• IVM Versus Standard IVF in Infertile Patients Diagnosed With PCOSStatus unknownNCT03463772Not applicable
• Pharmacokinetics and Pharmacodynamics of Ivermectin in Pediatric Dengue PatientsCompletedNCT03432442Phase 2
• A Bioequivalence Study, Comparing Two Formulations of Ivermectin Lotion, 0.5%CompletedNCT03257943Phase 1
• Insecticide Resistance Management in Burkina Faso and Côte D'IvoireCompletedNCT03074435Phase 3
• Ivermectin Treatment in Patients With Onchocerciasis-associated EpilepsyCompletedNCT03052998Phase 4
• Lymphatic Filariasis (LF) in Ivory CoastCompletedNCT02974049Not applicable
• Physiologically-based Pharmacokinetic Modeling of Ivermectin in Healthy Human VolunteersCompletedNCT02963324Phase 1
• Efficacy Study Between Two Different Dosages of an Antiparasitic in Patients With Crusted ScabiesCompletedNCT02841215Phase 3
• Efficacy and Safety of High-dose Ivermectin for Reducing Malaria Transmission: A Dose Finding StudyCompletedNCT02511353Phase 2
• Oral Ivermectin Versus Topical Permethrin to Treat Scabies in Children and AdultsCompletedNCT02407782Phase 3
• Treatment of Demodex Blepharitis With Ivermectin Gel 0.1% Plus Metronidazole 1%CompletedNCT02236403Phase 3
• Efficacy of Ivermectin and Albendazole Against Onchocerciasis in the Volta Region, GhanaCompletedNCT02078024Phase 3
• Efficacy and Safety of Ivermectin Against Dengue InfectionStatus unknownNCT02045069Phase 2/3
• Topical 0.5% Ivermectin Cream for Treatment of DemodicidosisStatus unknownNCT02036229Phase 3
• Eval 3-Drug Therapy Diethylcarbamize, Albendazole and Ivermectin That Could Accelerate LF Elimination Outside of AfricaCompletedNCT01975441Phase 2
• Safety Study of Combined Azithromycin, Ivermectin and Albendazole for Trachoma and Lymphatic FilariasisWithdrawnNCT01903057Phase 4
• Multiple Versus Single Dose of Ivermectin for the Treatment of StrongyloidiasisCompletedNCT01570504Phase 3
• Management of Soil-transmitted Helminthiasis and StrongyloidiasisStatus unknownNCT01308268Not applicable
• Safety and Efficacy of Drug Combinations Against Triple InfectionsCompletedNCT01050517Not applicable
• Safety and Efficacy of Drug Combinations Against Trichuris TrichiuraCompletedNCT01050452Not applicable
• Ivermectin Solution Bioequivalence Study - With FoodCompletedNCT00921674Phase 1
• Ivermectin Solution Bioequivalence Study - With Food (Repeat)CompletedNCT00921219Phase 1
• Ivermectin Solution Bioequivalence Study - FastedCompletedNCT00921154Phase 1
• Ivermectin in the Treatment of Head LiceCompletedNCT00819520Phase 3
• Can Presumptive Anthelminthic Treatment Delay the Progression of HIV in ART-naïve Patients in Rural Africa?TerminatedNCT00817713Not applicable
• Ivermectin Versus Albendazole for Chronic StrongyloidiasisCompletedNCT00765024Phase 3
• Veron Scabies Education and Eradication ProgramCompletedNCT00604084Not applicable
• Effect of Albendazole Dose on Clearance of Filarial WormsCompletedNCT00339417Phase 2
• Epidemiology and Control of Mansonella Perstans Infection in UgandaCompletedNCT00215280Not applicable

← Ivermectin overview